Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities - PubMed (original) (raw)
Review
Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities
Philamer C Calses et al. Trends Cancer. 2019 May.
Free article
Abstract
The Hippo pathway remains a central focus in both basic and translational research and is a key modulator of developmental biology. Dysregulation of the pathway is associated with a plethora of human cancers and there are multiple efforts to target key components of the pathway for disease intervention. In this review, we briefly highlight the latest research advances around the core components of the Hippo pathway in cancer. More specifically, we discuss several genetic aberrations of these factors as mechanisms for the development of cancers, including genetic amplification, deletion, and gene fusions. Additionally, we highlight the role of the Hippo pathway in cancer therapy resistance and tumor immunogenicity. Last, we summarize the ongoing efforts to target the pathway in cancers.
Keywords: Hippo pathway; TAZ; TEAD; YAP; cancer; drug development.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
- The Hippo pathway as a drug target in gastric cancer.
Qiao Y, Li T, Zheng S, Wang H. Qiao Y, et al. Cancer Lett. 2018 Apr 28;420:14-25. doi: 10.1016/j.canlet.2018.01.062. Epub 2018 Jan 31. Cancer Lett. 2018. PMID: 29408652 Review. - Targeting the Hippo Pathway for Anti-cancer Therapies.
Gong R, Yu FX. Gong R, et al. Curr Med Chem. 2015;22(35):4104-17. doi: 10.2174/0929867322666151002112256. Curr Med Chem. 2015. PMID: 26429069 Review. - Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer.
Mohajan S, Jaiswal PK, Vatanmakarian M, Yousefi H, Sankaralingam S, Alahari SK, Koul S, Koul HK. Mohajan S, et al. Cancer Lett. 2021 Jun 1;507:112-123. doi: 10.1016/j.canlet.2021.03.006. Epub 2021 Mar 15. Cancer Lett. 2021. PMID: 33737002 Free PMC article. Review. - The Role of Hippo Pathway in Cancer Stem Cell Biology.
Park JH, Shin JE, Park HW. Park JH, et al. Mol Cells. 2018 Feb 28;41(2):83-92. doi: 10.14348/molcells.2018.2242. Epub 2018 Feb 5. Mol Cells. 2018. PMID: 29429151 Free PMC article. Review. - Roles of RUNX in Hippo Pathway Signaling.
Passaniti A, Brusgard JL, Qiao Y, Sudol M, Finch-Edmondson M. Passaniti A, et al. Adv Exp Med Biol. 2017;962:435-448. doi: 10.1007/978-981-10-3233-2_26. Adv Exp Med Biol. 2017. PMID: 28299672 Free PMC article. Review.
Cited by
- Identification of resistance mechanisms to small-molecule inhibition of TEAD-regulated transcription.
Kulkarni A, Mohan V, Tang TT, Post L, Chan YC, Manning M, Thio N, Parker BL, Dawson MA, Rosenbluh J, Vissers JH, Harvey KF. Kulkarni A, et al. EMBO Rep. 2024 Sep;25(9):3944-3969. doi: 10.1038/s44319-024-00217-3. Epub 2024 Aug 5. EMBO Rep. 2024. PMID: 39103676 Free PMC article. - Mechanosensitive Ion Channel PIEZO1 Signaling in the Hall-Marks of Cancer: Structure and Functions.
Zhao F, Zhang L, Wei M, Duan W, Wu S, Kasim V. Zhao F, et al. Cancers (Basel). 2022 Oct 10;14(19):4955. doi: 10.3390/cancers14194955. Cancers (Basel). 2022. PMID: 36230880 Free PMC article. Review. - Pharmacological blockade of TEAD-YAP reveals its therapeutic limitation in cancer cells.
Sun Y, Hu L, Tao Z, Jarugumilli GK, Erb H, Singh A, Li Q, Cotton JL, Greninger P, Egan RK, Tony Ip Y, Benes CH, Che J, Mao J, Wu X. Sun Y, et al. Nat Commun. 2022 Nov 8;13(1):6744. doi: 10.1038/s41467-022-34559-0. Nat Commun. 2022. PMID: 36347861 Free PMC article. - MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer.
Lee NH, Kim SJ, Hyun J. Lee NH, et al. Biomedicines. 2021 Mar 30;9(4):347. doi: 10.3390/biomedicines9040347. Biomedicines. 2021. PMID: 33808155 Free PMC article. Review. - Cell adhesion molecule KIRREL1 is a feedback regulator of Hippo signaling recruiting SAV1 to cell-cell contact sites.
Paul A, Annunziato S, Lu B, Sun T, Evrova O, Planas-Paz L, Orsini V, Terracciano LM, Charlat O, Loureiro ZY, Ji L, Zamponi R, Sigoillot F, Lei H, Lindeman A, Russ C, Reece-Hoyes JS, Nicholson TB, Tchorz JS, Cong F. Paul A, et al. Nat Commun. 2022 Feb 17;13(1):930. doi: 10.1038/s41467-022-28567-3. Nat Commun. 2022. PMID: 35177623 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources